Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Agid

Showing results (181-190 of 611) with videos related to

Pageof 62
Sort By:
Annals of the New York Academy of Sciences|December 15, 1995
Planning and script analysis following prefrontal lobe lesionsA Sirigu, T Zalla, B Pillon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1996
Mycoplasma pneumoniae postinfectious encephalomyelitis with bilateral striatal necrosisJ P Brandel, M Vidailhet, G Noseda, et al.
Neurology|September 1, 1994
Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?M Vidailhet, A M Bonnet, R Marconi, et al.
Neuroscience|January 1, 1990
Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic studyF Thibaut, E C Hirsch, R Raisman, et al.
Advances in Neurology|January 1, 1975
Dopamine receptors and cholinergic neurons in the rat neostriatumP G Guyenet, F Javoy, Y Agid, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|November 4, 1998
Deficit in evaluating pre-determined sequences of script events in patients with Parkinson's diseaseT Zalla, A Sirigu, B Pillon, et al.
Annals of Neurology|May 1, 1993
Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteinsP Vermersch, A Delacourte, F Javoy-Agid, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Neuronal vulnerability in Parkinson's diseaseE C Hirsch, B Faucheux, P Damier, et al.
Journal of Neurochemistry|May 1, 1997
Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?M Ruberg, B Brugg, A Prigent, et al.
Lancet (London, England)|March 17, 1979
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's diseaseY Agid, P Pollak, A M Bonnet, et al.
Pageof 62

Showing results (181-190 of 611) with videos related to

Sort By:
Pageof 62
Annals of the New York Academy of Sciences|December 15, 1995
Planning and script analysis following prefrontal lobe lesionsA Sirigu, T Zalla, B Pillon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1996
Mycoplasma pneumoniae postinfectious encephalomyelitis with bilateral striatal necrosisJ P Brandel, M Vidailhet, G Noseda, et al.
Neurology|September 1, 1994
Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?M Vidailhet, A M Bonnet, R Marconi, et al.
Neuroscience|January 1, 1990
Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic studyF Thibaut, E C Hirsch, R Raisman, et al.
Advances in Neurology|January 1, 1975
Dopamine receptors and cholinergic neurons in the rat neostriatumP G Guyenet, F Javoy, Y Agid, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|November 4, 1998
Deficit in evaluating pre-determined sequences of script events in patients with Parkinson's diseaseT Zalla, A Sirigu, B Pillon, et al.
Annals of Neurology|May 1, 1993
Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteinsP Vermersch, A Delacourte, F Javoy-Agid, et al.
Journal of Neural Transmission. Supplementum|January 1, 1997
Neuronal vulnerability in Parkinson's diseaseE C Hirsch, B Faucheux, P Damier, et al.
Journal of Neurochemistry|May 1, 1997
Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?M Ruberg, B Brugg, A Prigent, et al.
Lancet (London, England)|March 17, 1979
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's diseaseY Agid, P Pollak, A M Bonnet, et al.
Pageof 62